Author Archives: Natalie Themm
Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems
Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease
Fluidx Unveils New Embolic for Neurovascular Use
New Catheter-Delivered Embolic Shows Promise for Treating Life-Threatening Bleeding around the Brain
Nomi Health Hires Global Health and Technology Leader Amy Wykoff as Company’s First Chief Product Officer
Wykoff to build upon more than two decades of public and private sector healthcare leadership to head up delivering Nomi Health’s core business offerings
IONIQ is “Clinical Diagnostics Solution of the Year 2022”
IONIQ is “Clinical Diagnostics Solution of the Year 2022”
IONIQ Science 2022 year-end update
For IONIQ Sciences, 2022 was another big year. As we respond to the FDA’s substantive review of our De Novo application for the ‘breakthrough‘ IONIQ ProLung Test, powerful macroeconomic factors are highlighting the importance of early cancer detection. Despite uncertain conditions in the financial market, we have a compelling message for potential institutional and strategic investors at […]
Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition
Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654
NEW DIGITAL HEALTH INITIATIVE TO CREATE NEXT GENERATION OF MEDICAL APPS, GAMES, AND TECHNOLOGIES
The University of Utah Health has launched NEW DIGITAL HEALTH INITIATIVE
Teva Announces Appointment of Richard Francis as President and CEO
Kåre Schultz to Retire After a Transformative Five-Year Tenure Setting the Stage for an Exciting Future
CenExel Creates Clinical Sciences Business Unit
CenExel announces a new Clinical Sciencesbusiness unit and more.
Betty Iverson Retirement
Betty Iverson Retirement Announced
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update
PolarityTE provided a business update and reported financial results for the quarterly period ended September 30, 2022.
PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company
PolarityTE confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November 8, 2022) from Michael Brauser to acquire all of the outstanding common stock of the Company not owned by him for $1.25 per share in cash.
